The Global Companion Diagnostics Market accounted to USD 9.40 billion out of 2024, developing at a CAGR of 19.8% amid the figure time of 2017 to 2024. The up and coming business sector report contains information for noteworthy year 2015, the base year of computation is 2016 and the estimate time frame is 2017 to 2024.
Companion Diagnostics Market accounted to USD 9.40 billion in 2024, growing at a CAGR of 19.8% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Companion Diagnostics Market Definition:
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic treatment of patients through which they can be benefitted from certain drug dosage according to their diagnosis, allergies and necessity. Here much technological advancement has been made in order to improve this along with the growing requirements for enhanced personalized patient treatment so that complete assurance must be given by the doctors.
Access Free Sample Report@ bit.ly/2tiibZH
Major Market Drivers and Restraints:
- Increasing number of genetic testing
- Growing technological development
- Increase in cost related to technological advancement
Companion Diagnostics Market Segmentation:
On the basis of product and services, global companion diagnostics market is segmented into
- assay kits
- software & services.
On the basis of technology, global companion diagnostics market is segmented into
- polymerase chain reaction,
- next-generation sequencing
- in situ hybridization.
On the basis of indication, global companion diagnostics market is segmented into
- infectious diseases
oncology is sub segmented into
- breast cancer,
- lung cancer,
- colorectal cancer,
- gastric cancer and melanoma.
On the basis of end users global companion diagnostics market is segmented into
- biopharmaceutical companies
- reference laboratories.
On the basis of geography, global companion diagnostics market report covers data points for 28 countries across multiple geographies namely
- North America & South America,
- Europe, Asia-Pacific,
- Middle East & Africa.
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Make enquiries @ bit.ly/2D46mpy
Companion Diagnostics Market Competitive Analysis:
The global companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes companion diagnostics shares for global, Europe, North America, Asia Pacific, and South America.
Major Market Competitors:
Some of the major players operating in companion diagnostics market are
- Hoffmann La Roche Diagnostics,
- QIAGEN ,
- Agilent Technologies,
- Ventana Medical Systems Inc.,
- Myriad Genetics,
- Leica Biosystems Nussloch GmbH,
- RESONANCE HEALTH,
- ARUP Laboratories,
- Life Technologies,
- Thermo Fisher Scientific Inc.,
- bioMerieux SA among others.
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...